Benzo(a)pyrene diolepoxide adducts to albumin in workers exposed to polycyclic aromatic hydrocarbons: association with specific CYP1A1, GSTM1, GSTP1 and EHPX genotypes

References

• ALEXANDRIE, A. K., WARHOLM, M., CARSTENSEN, U., AXMON, A., HAGMAR, L., LEVIN, J. O., OSTMAN, C. and RANNUG, A. 2000, CYP1A1 and GSTM1 polymorphisms affect urinary 1-hydroxypyrene levels after PAH exposure. Carcinogenesis, 21, 669–676.
   PubMed Web of Science ®Google Scholar
• ALI-OSMAN, F., AKANDE, O., AyrouN, G., MAO, J. X. and BUOLAMWINI, J. 1997, Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferaw Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. Journal of Biological Chemistry, 272, 10004–10012.
   Google Scholar
• AUTRUP, H., VESTERGAARD, A. B. and OKKELS, H. 1995, Transplacental transfer of environmental genotoxins: polycyclic aromatic hydrocarbon-albumin in non-smoking women, and the effect of maternal GSTM1 genotype. Carcinogenesis, 16, 1305–1309.
   PubMed Web of Science ®Google Scholar
• BARTSCH, H., NAIR, U., RISCH, A., ROJAS, M., WIKMAN, H. and ALEXANDROV, K. 2000, Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiology Biomarkers CI Prevention, 9, 3–28.
   PubMed Web of Science ®Google Scholar
• BELL, D. A., THOMPSON, C. L., TAYLOR, J., MILLER, C. R., PERERA, F., HSIEH, L. L. and LUCIER, G. W. 1992, Genetic monitoring of human polymorphic cancer susceptibility genes by polymerase chain reaction: application to glutathione transferase mu. Environmental Health Perspectives, 98, 113–117.
   PubMed Web of Science ®Google Scholar
• BENHAMOU, S., REINIKAINEN, M., BOUCHARDY, C., DAYER, P. and HIRVONEN, A. 1998, Association between lung cancer and microsomal epoxide hydrolase genotypes. Cancer Research, 58, 5291–5293.
   PubMed Web of Science ®Google Scholar
• BINKOVA, B., TOPINKA, J., MRACKOVA, G., GAJDOSOVA, D., VIDOVA, P., STAVKOVA, Z., PETERKA, V., PILCIK, T., RIMAR, V., DOBIAS, L., FARMER, P. B. and SRAM, R. J. 1998, Coke oven workers study: the effect of exposure and GSTM1 and NAT2 genotypes on DNA adduct levels in white blood cells and lymphocytes as determined by 32P-postlabelling. Mutation Research, 416, 67–84.
   PubMed Web of Science ®Google Scholar
• BOFFETTA, P., JOURENKOVA, N. and GUSTAVSSON, P. 1997, Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes and Control, 8, 444–472.
   PubMed Web of Science ®Google Scholar
• BUTKIEWICZ, D., GRZYBOWSKA, E., HEMMINKI, K., OVREBO, S., HAUGEN, A., MOTYKIEWICZ, G. and CHORAZY, M. 1998, Modulation of DNA adduct levels in human mononuclear white blood cells and granulocytes by CYP1A1 CYP2D6 and GSTM1 genetic polymorphisms. Mutation Research, 415, 97–108.
   PubMed Web of Science ®Google Scholar
• BUTKIEWICZ, D., GRZYBOWSKA, E., PHILLIPS, D. H., HEMMINKI, K. and CHORAZY, M. 2000, Polymorphisms of the GSTP1 and GSTM1 genes and PAH—DNA adducts in human mononuclear white blood cells. Environmental Molecular Mutagenesis, 35, 99–105.
   PubMed Web of Science ®Google Scholar
• CASCORBI, I., BROCKMOLLER, J. and ROOTS, I. 1996, A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Research, 56, 4965–4969.
   PubMed Web of Science ®Google Scholar
• DAY, B. W., NAYLOR, S., GAN, L. S., SAHALI, Y., NGUYEN, T. T., SKIPPER, P. L., WISHNOK, J. S. and TANNENBAUM, S. R. 1990, Molecular dosimetry of polycyclic aromatic hydrocarbon epoxides and diol epoxides via hemoglobin adducts. Cancer Research, 50, 4611–4618.
   PubMed Web of Science ®Google Scholar
• DELLOMO, M. and LACWERYS, R. R. 1993, Adducts to macromolecules in the biological monitoring of workers exposed to polycyclic aromatic hydrocarbons. Critical Reviews in Toxicology, 23, 111–126.
   PubMed Web of Science ®Google Scholar
• GAEDIGK, A., SPIELBERG, S. P. and GRANT, D. M. 1994, Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactions. Pharmacogenetics, 4, 142–153.
   PubMedGoogle Scholar
• GELBOIN, H. V. 1980, Benzo[a/pha]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiological Reveiws, 60, 1107–1166.
   PubMed Web of Science ®Google Scholar
• HARRIS, M. J., COGGAN, M., LANGTON, L., WILSON, S. R. and BOARD, P. G. 1998, Polymorphism of the Pi class glutathione S-transferase in normal populations and cancer patients. Pharmacogenetics, 8, 27–31.
   PubMedGoogle Scholar
• HASSETT, C., AICHER, L., SIDHU, J. S. and OMIECINSKI, C. J. 1994, Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants [published erratum appears in Hum Mol Genet 1994 Jul:3(7):1214]. Human Molecular Genetics, 3, 421–428.
   PubMed Web of Science ®Google Scholar
• HASSETT, C., LIN, J., CARTY, C. L., LAURENZANA, E. M. and OMIECINSKI, C. J. 1997, Human hepatic microsomal epoxide hydrolase: comparative analysis of polymorphic expression. Archives of Biochemistry and Biophyisics, 337, 275–283.
   PubMed Web of Science ®Google Scholar
• HEMMINKI, K., DICKEY, C., KARLSSON, S., BELL, D., Hsu, Y., TSAI, W. Y., MOONEY, L. A., SAVELA, K. and PERERA, F. P. 1997, Aromatic DNA adducts in foundry workers in relation to exposure, life style and CYP1A1 and glutathione transferase M1 genotype. Carcinogenesis, 18, 345–350.
   PubMed Web of Science ®Google Scholar
• Hu, X., Ji, X., SRIVASTAVA, S. K., XIA, H., AWASTHI, S., NANDURI, B., AWASTHI, Y. C., ZIMNIAK, P. and SINGH, S. V. 1997a, Mechanism of differential catalytic efficiency of two polymorphic forms of human glutathione S-transferase P1-1 in the glutathione conjugation of carcinogenic diol epoxide of chrysene. Archives of Biochemistry and Biophyisks, 345, 32–38.
   PubMed Web of Science ®Google Scholar
• Hu, X., XIA, H., SRIVASTAVA, S. K., HERZOG, C., AWASTHI, Y. C., J1, X., ZIMNIAK, P. and SINGH, S. V. 1997b, Activity of four allelic forms of glutathione S-transferaw hGSTP1-1 for diol epoxides of polycyclic aromatic hydrocarbons. Biochemical and Biophysical Research Communkations, 238, 397–402.
   Google Scholar
• Hu, X., HERZOG, C., ZIMNIAK, P. and SINGH, S. V. 1999, Differential protection against benzo[a]pyrene-7,8-dihydrodio1-9,10-epoxide-induced DNA damage in HepG2 cells stably transfected with allelic variants of pi class human glutathione S-transferase. Cancer Research, 59, 2358–2362.
   PubMed Web of Science ®Google Scholar
• ICHIBA, M., HAGMAR, L., RANNUG, A., HOGSTEDT, B., ALEXANDRIE, A. K., CARSTENSEN, U. and HEMMINKI, K. 1994, Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GST1 in chimney sweeps. Carcinogenesis, 15, 1347–1352.
   PubMed Web of Science ®Google Scholar
• INGELMAN-SUNDBERG, M., DALY, A. K., OSCARSON, M. and NEBERT, D. W. 2000, Human cytochrome P450 (CYP) genes: recommendations for the nomenclature of alleles [letter]. Pharmacogenetics, 10, 91–93.
   Google Scholar
• JOURENKOVA-MIRONOVA, N., WIKMAN, H., BOUCHARDY, C., VOHO, A., DAYER, P., BENHAMOU, S. and HIRVONEN, A. 1998, Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer. Pharmacogenetics, 8, 495–502.
   PubMedGoogle Scholar
• JOURENKOVA-MIRONOVA, N., MITRUNEN, K., BOUCHARDY, C., DAYER, P., BENHAMOU, S. and HIRVONEN, A. 2000, High-activity microsomal epoxide hydrolase genotypes and the risk of oral, pharynx, and larynx cancers. Cancer Research, 60, 534–536.
   PubMed Web of Science ®Google Scholar
• KETTERER, B., HARRIS, J. M., TALASKA, G., MEYER, D. J., PEMBLE, S. E., TAYLOR, J. B., LANG, N. P. and KADLUBAR, F. F. 1992, The human glutathione S-transferaw supergene family, its polymorphism, and its effects on susceptibility to lung cancer. Environmental Health Perspectives, 98, 87–94.
   PubMed Web of Science ®Google Scholar
• LANDI, M. T., BERTAZZI, P. A., SHIELDS, P. G., CLARK, G., LUCIER, G. W., GARTE, S. J., COSMA, G. and CAPORASO, N. E. 1994, Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics, 4, 242–246.
   PubMedGoogle Scholar
• LAURENZANA, E. M., HASSETT, C. and OMIECINSKI, C. J. 1998, Post-transcriptional regulation of human microsomal epoxide hydrolase. Pharmacogenetics, 8, 157–167.
   PubMedGoogle Scholar
• MATTHIAS, C., BOCKMUHL, U., JAHNKE, V., HARRIES, L. W., WOLF, C. R., JONES, P. W., ALLDERSEA, J., WORRALL, S. F., HAND, P., FRYER, A. A. and STRANGE, R. C. 1998, The glutathione S-transferase GSTP1 polymorphism: effects on susceptibility to oral/pharyngeal and laryngeal carcinomas. Pharmacogenetics, 8, 1–6.
   PubMedGoogle Scholar
• MCGLYNN, K. A., ROSVOLD, E. A., LUSTBADER, E. D., Hu, Y., CLAPPER, M. L., ZHOU, T., WILD, C. P., XIA, X. L., BAFFOE-BONNIE, A., OFORI-ADJEI, D., CHEN, G., LONDON, W. T., SHEN, F. and Buwrow, K. H. 1995, Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin Bl. Proceedings of the National Academy of Sciences of the USA, 92, 2384–2387.
   Google Scholar
• MOONEY, L. A., BELL, D. A., SANTELLA, R. M., VAN BENNEKUM, A. M., OTTMAN, R., PAIK, M., BLANER, W. S., LUCIER, G. W., COVEY, L., YOUNG, T. L., COOPER, T. B., GLASSMAN, A. H. and PERERA, F. P. 1 997, Contribution of genetic and nutritional factors to DNA damage in heavy smokers. Carcinogenesis, 18, 503–509.
   Google Scholar
• NAYLOR, S., GAN, L. S., DAY, B. W., PASTORELLI, R., SKIPPER, P. L. and TANNENBAUM, S. R. 1990, Benzo[a]pyrene diol epoxide adduct formation in mouse and human hemoglobin: physicochemical basis for dosirnetry. Chemical Research in Toxicology, 3, 111–117.
   PubMed Web of Science ®Google Scholar
• OMIECINSKI, C. J., AICHER, L., HOLUBKOV, R. and CHECKOWAY, H. 1993, Human peripheral lymphocytes as indicators of microsomal epoxide hydrolase activity in liver and lung. Pharmacogenetics, 3, 150–158.
   PubMedGoogle Scholar
• OMLAND, O., SHERSON, D., HANSEN, A. M., SIGSGAARD, T., AUTRUP, H. and OVERGAARD, E. 1994, Exposure of iron foundry workers to polycyclic aromatic hydrocarbons: benzo(a)pyrene-albumin adducts and 1-hydroxypyrene as biomarkers for exposure. Occupational and Environmental Medicine, 51, 513–518.
   PubMed Web of Science ®Google Scholar
• OZBAL, C. C., SKIPPER, P. L., Yu, M. C., LONDON, S. J., DASARI, R. R. and TANNENBAUM, S. R. 2000, Quantification of (7 S, 8R)-dihydroxy -(9 R,1 OS)-epoxy-7,8,9,10-tetrahydrobenzo[ a]pyrene ad-ducts in human serum albumin by laser-induced fluorescence: implications for the in vivo metabolism of benzo[a]pyrene [In Process Citation]. Cancer Epidemiology Biomarkers Prevention, 9, 733–739.
   PubMed Web of Science ®Google Scholar
• PARK, J. Y., SCHANTZ, S. P., STERN, J. C., KAUR, T. and LAZARUS, P. 1999, Association between glutathione S-transferaw pi genetic polymorphisms and oral cancer risk [published erratum appears in Pharmacogenetics 2000 Jun;10(4):371]. Pharmacogenetics, 9, 497–504.
   PubMedGoogle Scholar
• PASTORELLI, R., RESTANO, J., GUANCI, M., MARAMONTE, M., MAGAGNOTTI, C., ALLEVI, R., LAURI, D., FANELLI, R. and AIROLDI, L. 1996, Hemoglobin adducts of benzo[a]pyrene diolepoxide in newspaper vendors: association with traffic exhaust. Carcinogenesis, 17, 2389–2394.
   PubMed Web of Science ®Google Scholar
• PASTORELLI, R., GUANCI, M., CERRI, A., NEGRI, E., LA VECCHIA, C., FUMAGALLI, F., MEZZETTI, M., CAPPELLI, R., PANIGALLI, T., FANELLI, R. and AIROLDI, L. 1998, Impact of inherited polymorphisms in glutathione S-transferaw Ml, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene-diolepoxide. Cancer Epidemiology Biomarkers CI Prevention, 7, 703–709.
   PubMed Web of Science ®Google Scholar
• PASTORELLI, R., GUANCI, M., CERRI, A., MINOIA, C., CARRER, P., NEGRI, E., FANELLI, R. and AIROLDI, L. 2000, Benzo(a)pyrene diolepoxide-hemoglobin and albumin adducts at low levels of benzo(a)pyrene exposure. Biomarkers, 5, 245–251.
   PubMed Web of Science ®Google Scholar
• ROJAS, M., ALEXANDROV, K., CASCORBI, I., BROCKMOLLER, J., LIKHACHEV, A., POZHARISSKI, K., BOUVIER, G., AUBURTIN, G., MAYER, L., KOPP-SCHNEIDER, A., ROOTS, I. and BARTSCH, H. 1998, High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/Msp-GSTM1*0/*0 genotypes. Pharmacogenetics, 8, 109–118.
   PubMedGoogle Scholar
• ROJAS, M., CASCORBI, I., ALEXANDROV, K., KRIEK, E., AUBURTIN, G., MAYER, L., KOPP-SCHNEIDER, A., ROOTS, I. and BARTSCH, H. 2000, Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism. Carcinogenesis, 21, 35–41.
   PubMed Web of Science ®Google Scholar
• ROTHMAN, N., SHIELDS, P. G., POIRIER, M. C., HARRINGTON, A. M., FORD, D. P. and STRICKLAND, P. T. 1995, The impact of glutathione S-transferaw M1 and cytochrome P450 1A1 genotypes on white-blood-cell polycyclic aromatic hydrocarbon-DNA adduct levels in humans. Molecular Carcinogenesis, 14, 63–68.
   PubMed Web of Science ®Google Scholar
• RYBERG, D., SKAUG, V., HEWER, A., PHILLIPS, D. H., HARRIES, L. W., WOLF, C. R., OGREID, D., ULvix, A., Vu, P. and HAUGEN, A. 1997, Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis, 18, 1285–1289.
   PubMed Web of Science ®Google Scholar
• SCHOKET, B., PHILLIPS, D. H., KOSTIC, S. and VINCZE, I. 1998, Smoking-associated bulky DNA adducts in bronchial tissue related to CYP1A1 MspI and GSTM1 genotypes in lung patients. Carcinogenesis, 19, 841–846.
   PubMed Web of Science ®Google Scholar
• SHERSON, D., SABRO, P., SIGSGAARD, T., JOHANSEN, F. and AUTRUP, H. 1990, Biological monitoring of foundry workers exposed to polycyclic aromatic hydrocarbons. British Journal of Industrial Medicine, 47, 448–453.
   PubMedGoogle Scholar
• SHIELDS, P. G., BOWMAN, E. D., HARRINGTON, A. M., DOAN, V. T. and WESTON, A. 1993, Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Research, 53, 3486–3492.
   PubMed Web of Science ®Google Scholar
• SKIPPER, P. L. and TANNENBAUM, S. R. 1990, Protein adducts in the molecular dosimetry of chemical carcinogens. Carcinogenesis, 11, 507–518.
   PubMed Web of Science ®Google Scholar
• SMITH, C. A. and HARRISON, D. J. 1997, Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema [see comments]. Lancet, 350, 630–633.
   PubMed Web of Science ®Google Scholar
• TAS, S., BUCHET, J. P. and LACWERYS, R. 1994, Determinants of benzo[a]pyrene diol epoxide adducts to albumin in workers exposed to polycyclic aromatic hydrocarbons. International Archives of Occupational CI Environmental Health, 66, 343–348.
   PubMed Web of Science ®Google Scholar
• VIEZZER, C., NORPPA, H., CLONFERO, E., GABBANI, G., MASTRANGELO, G., HIRVONEN, A. and CELOTTI, L. 1999, Influence of GSTM1, GSTT1, GSTP1, and EPHX gene polymorphisms on DNA adduct level and HPRT mutant frequency in coke-oven workers [see comments]. Mutation Research, 431, 259–269.
   PubMed Web of Science ®Google Scholar
• WATSON, M. A., STEWART, R. K., SMITH, G. B., MASSEY, T. E. and BELL, D. A. 1998, Human glutathione S-transferaw P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis, 19, 275–280.
   PubMed Web of Science ®Google Scholar
• WORMHOUDT, L. W., COMMANDEUR, J. N. M. and VERMEULEN, N. P. E. 1999, Gentic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity. Critical Reviews in Toxicology, 29, 59–124.
   Google Scholar
• WORLD HEALTH ORGANIZATION 1984, Polynuclear aromatic compounds. Part 3: Industrial exposure in aluminum production, coal gasification, coke production and iron and steel founding., IARC Monographs: Evaluation of Carcinogenic Risk of Chemicals to Humans, Vol. 34 (Lyon: IARC).
   Google Scholar
• WORLD HEALTH ORGANIZATION 1999, Metabolic polymorphisms and susceptibility to cancer. IARC Scientific Publication No. 148 (Lyon: IARC).
   Google Scholar